Current funding
Active research funding supporting resolution pharmacology, specialised pro-resolving mediators, cardiovascular disease, oral pre-malignant lesions and inflammation biology.
Marie Sklodowska-Curie
Actions
2025
PI
HARPNET – Harnessing Resolution Pharmacology for Next-Generation Therapeutics
Funded by Marie Sklodowska Curie Doctoral Networks
Cancer Research
UK
2025
Co-I
Investigating the protective activities of Maresins in oral pre-malignant lesions
Funded by Cancer Research UK
Barts
Charity
2025
PI
Characterizing the biology of a novel GPCR in neutrophils
Funded by Barts Charity
COST
Actions
2025
PI
EU-Resolution Biology Network
Funded by COST Actions
Barts
Charity
2024
Co-I
Pathogenesis and prevention of cardiovascular disease in prostate cancer patients undergoing hormonal treatments – the role of specialised pro-resolving lipid mediators
Funded by Barts Charity Seed Grant
Barts
Charity
2024
Co-I
Early detection of OPSCC through salivary specialized lipid mediator profiling
Funded by Barts Charity Seed Grant
Arctic
Biosciences
2024
PI
Evaluating the role of SPM in mediating the biological activities of marine oils
Funded by Arctic Biosciences
Wellcome
Trust
2023-2028
Co-I
Extreme heat and preterm birth in rural Zimbabwe
Funded by Wellcome Trust
Prof Jesmond Dalli
Lipid Mediator Unit,
Centre for Biochemical Pharmacology
John Vane Science Centre,
Charterhouse Square,
London, EC1M 6BQ, United Kingdom
Phone: +44 (0) 207 882 8263
Email: j.dalli@qmul.ac.uk